1. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies
by Sabine Kayser, Manuela Zucknick, Konstanze Döhner, Jürgen Krauter, Claus-Henning Köhne, Heinz A. Horst, Gerhard Held, Marie von Lilienfeld-Toal, Sibylla Wilhelm, Mathias Rummel, Ulrich Germing, Katharina Götze, David Nachbaur, Brigitte Schlegelberger, Gudrun Göhring, Daniela Späth, Carina Morlok, Veronica Teleanu, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk, and
Blood
Volume 119(2):
January 12, 2012
©2012 by American Society of Hematology

2. Survival curves according to MK and CK
Survival curves according to MK and CK. (A) Impact of MK in patients exhibiting a CK and (B) impact of CK in patients exhibiting a MK.
Survival curves according to MK and CK. (A) Impact of MK in patients exhibiting a CK and (B) impact of CK in patients exhibiting a MK.
Sabine Kayser et al. Blood 2012;119:
©2012 by American Society of Hematology

3. Survival curves according to MK and WHO category MDS-related changes.
Survival curves according to MK and WHO category MDS-related changes. (A) Impact of MK in patients exhibiting MDS-related cytogenetic abnormalities and (B) impact of MDS-related cytogenetic abnormalities in patients exhibiting a MK.
Sabine Kayser et al. Blood 2012;119:
©2012 by American Society of Hematology

4. Survival curves according to induction result and post remission treatment.
Survival curves according to induction result and post remission treatment. (A) OS measured from date of first CR in younger MK patients achieving a CR after induction therapy according to treatment strategy. (B) OS measured from date of transplantation in younger MK patients refractory to induction therapy according to type of donor.
Sabine Kayser et al. Blood 2012;119:
©2012 by American Society of Hematology